Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-264
Closed -$1.19K 5048
2025
Q4
$1.19K Hold
264
﹤0.01% 3576
2025
Q3
$1.42K Sell
264
-522
-66% -$2.83K ﹤0.01% 3394
2025
Q2
$4.27K Buy
+786
New +$3.12K ﹤0.01% 3128

MAI Capital Management's CVAC Position: Q1 2026 in Review

MAI Capital Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 264 shares — an estimated $1.19K sold.

MAI Capital Management first reported a position in CVAC in Q2 2025 and held it in 3 quarters. The position peaked at $4.27K in Q2 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • MAI Capital Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • MAI Capital Management sold 264 CureVac shares in Q1 2026, an estimated $1.19K.
  • MAI Capital Management first reported a position in CureVac in Q2 2025 and held it in 3 quarters.
  • MAI Capital Management's CureVac position peaked at $4.27K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.